Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Cancer Clin Oncol. 2012 Dec 21;2(1):51–61. doi: 10.5539/cco.v2n1p51

Table 1.

Cohort Characteristics

Characteristics Total p16+ve p16−ve p-value HPV16+ve HPV16−ve p-value

N=80 N=21 (%) N=59 (%) N=40 (%) N=40 (%)
Gender
Male 66 16 (24) 50 (76) 0.376 34 32 0.556
Female 14 5 (36) 9 (64) 6 8
Age Group
≤50 years 12 5 (42) 7 (58) 0.302 8 (67) 4 (33) 0.293
51-65 years 32 9 (28) 23 (72) 17 (53) 15 (47)
>65 years 36 7(19) 29 (81) 15 (42) 21 (58)
Marital Status
Unmarried 28 12 (43) 16 (57) 0.008 12 (43) 16 (57) 0.254
Married 46 7 (15) 39 (85) 26 (57) 20 (43)
Smoking
Never smoker 10 6 (60) 4 (40) 0.014 7 (70) 3 (30) 0.455
Past smoker 27 9 (33) 18 (67) 12 (44) 15 (56)
Current smoker 39 6 (15) 33 (85) 20 (51) 19 (49)
Race *
Caucasian American (CA) 40 15 (38) 25 (62) 0.031 26 (65) 14 (35) 0.013
African American (AA) 38 6 (16) 32 (84) 14 (37) 24 (63)
p16 Status
Positive 21 12 (57) 9 (43) 0.446
Negative 59 28 (47) 31(53)
HPV16 Status
Positive 40 12 (30) 28 (70) 0.446
Negative 40 9 (23) 31 (77)
Sites
Oropharynx 20 13 (65) 7 (35) <0.001 10 (50) 10 (50) 1.000
Non-Oropharynx 60 8 (13) 52 (87) 30 (50) 30 (50)
Oral Cavity 20 4 (20) 16 (80) 0.004 10 (50) 10 (50)
Larynx 20 3 (15) 17 (85) 0.001 10 (50) 10 (50)
Hypopharynx 20 1 (5) 19 (95) <0.001 10 (50) 10 (50)
Stage
Early 19 2 (11) 17 (89) 0.073 8 (42) 11 (58) 0.792
Late 53 18 (34) 35 (66) 25 (47) 28 (53)

Marital status missing for 6 cases;

*

Other race (N=2) are p16 negative, HPV16 negative and are located in Hypopharynx;

significant p-values; OP - oropharynx; p16+ve: p16 positive, p16−ve: p16 negative, HPV16+ve: HPV16 positive, HPV16−ve: HPV16 negative